abstract |
The present invention relates to therapeutic activities and selective inhibitors of the enzyme DPP-IV, pharmaceutical compositions comprising said compounds, and diseases associated with proteins that are inactivated by DDP-IV, such as type II diabetes and obesity. To the use of such compounds for the manufacture of a medicament for treating. |